• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Moderna takes first autoimmune therapeutic candidate into the clinic

cafead

Administrator
Staff member
  • cafead   Aug 02, 2021 at 11:22: AM
via Moderna has dosed the first participant in a Phase 1 study of its IL-2 mRNA therapeutic, mRNA-6231.

article source